PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 84 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $73,000 | -60.3% | 172,643 | +10.0% | 0.00% | -100.0% |
| Q4 2015 | $184,000 | +30.5% | 157,013 | +13.5% | 0.00% | – |
| Q3 2015 | $141,000 | -18.0% | 138,288 | +5.5% | 0.00% | -100.0% |
| Q2 2015 | $172,000 | -9.9% | 131,131 | -7.2% | 0.00% | 0.0% |
| Q1 2015 | $191,000 | +25.7% | 141,281 | +29.0% | 0.00% | – |
| Q4 2014 | $152,000 | -5.0% | 109,481 | -7.0% | 0.00% | – |
| Q3 2014 | $160,000 | -19.6% | 117,696 | +11.2% | 0.00% | -100.0% |
| Q2 2014 | $199,000 | +22.1% | 105,796 | +23.4% | 0.00% | – |
| Q1 2014 | $163,000 | +27.3% | 85,710 | -6.9% | 0.00% | – |
| Q4 2013 | $128,000 | -3.8% | 92,040 | -2.6% | 0.00% | – |
| Q3 2013 | $133,000 | +11.8% | 94,540 | +2.7% | 0.00% | – |
| Q2 2013 | $119,000 | – | 92,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |